These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3735303)

  • 1. Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
    van der Huizen AA; Wilting T; van de Grampel JC; Lelieveld P; van der Meer-Kalverkamp A; Lamberts HB; Mulder NH
    J Med Chem; 1986 Aug; 29(8):1341-5. PubMed ID: 3735303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.
    MacDiarmid JE; Rose WC; Biddle WC; Perlman ME; Breiner RG; Ambrus JL; Bardos TJ
    J Med Chem; 1985 Nov; 28(11):1685-91. PubMed ID: 4067995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumour activity of some cyclophosphazenes.
    Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents.
    Hsiao YY; Bardos TJ; Wampler GL; Regelson W
    J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostatic activity in vitro of some new cyclophosphazene oligomers.
    Duś D; Brandt K; Wojdat E; Gebarowska E; Jedliński Z; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):539-46. PubMed ID: 2487365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorus-nitrogen compounds. 21. Murine oncolytic and antifertility effect of adamantylaziridine compounds.
    Cates LA; Cramer MB; Williams L
    J Med Chem; 1978 Jan; 21(1):143-6. PubMed ID: 619145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-to-date improvements in inorganic ring systems as anticancer agents.
    Labarre JF
    Top Curr Chem; 1982; 102():1-87. PubMed ID: 6750846
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential anti-tumour 2,5-bis (1-aziridinyl)-1,4-benzoquinones: relationship between cytotoxicity against DNA-repair deficient E. coli, inactivation of bacteriophage M13mp19, and in vitro and in vivo anti-tumour activity.
    Lusthof KJ; Groothuis-Pielage IL; Decuyper J; de Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1988 Dec; 3(3):147-55. PubMed ID: 3061386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activity of P,P-bis(2-methyl-1-aziridinyl)-N-2-pyrimidinylphosphinic amide (methylphosphazine) and related compounds.
    Noell CW; Cheng CC
    J Med Chem; 1968 Jan; 11(1):63-6. PubMed ID: 4966062
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of 5'-thymidinyl bis(1-aziridinyl)phosphinates as antineoplastic agents.
    Hsiao LY; Bardos TJ
    J Med Chem; 1981 Jul; 24(7):887-9. PubMed ID: 7277400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.
    Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ
    J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.
    Zijlstra JG; de Jong S; van de Grampel JC; de Vries EG; Mulder NH
    Cancer Res; 1986 Jun; 46(6):2726-9. PubMed ID: 3008999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.
    Malfiore C; Marmonti L; Filippeschi S; Labarre JF; Spreafico F
    Anticancer Res; 1983; 3(6):425-9. PubMed ID: 6230986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of trans-N3P3Az2(NHMe)4 (AZP) in non-small cell lung cancer.
    Postmus PE; Mulder NH; Grampel JC; Meyers WH; Berendsen HH
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1207-8. PubMed ID: 2820748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of BM 12,531 (Prop. INN azimexon).
    Bicker U
    Recent Results Cancer Res; 1980; 75():147-52. PubMed ID: 7232826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of aziridinylallylaminophosphine oxides and sulfides as potential adjuvant cancer chemotherapeutic agents.
    Tsou KC; Bender D; Santora N; David L; Damle S
    J Med Chem; 1976 Jun; 19(6):806-10. PubMed ID: 950650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorus-nitrogen compounds XIX: distribution of 32P and effect of an active oncolytic on intracerebral leukemia in rodents.
    Cates LA; Cramer MB
    J Pharm Sci; 1976 Mar; 65(3):439-40. PubMed ID: 1263100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
    Giorgi-Renault S; Renault J; Gebel-Servolles P; Baron M; Paoletti C; Cros S; Bissery MC; Lavelle F; Atassi G
    J Med Chem; 1991 Jan; 34(1):38-46. PubMed ID: 1992140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between potential anti-tumour 2,5-bis(1-aziridinyl)-1,4-benzoquinone derivatives and glutathione: reductive activation, conjugation and DNA damage.
    Lusthof KJ; de Mol NJ; Janssen LH; Prins B; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1990 Aug; 5(3):283-90. PubMed ID: 2205226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group.
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):143-6. PubMed ID: 4038653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.